NRXPW vs NTAP · rev $242.0K vs P/E 28, rev $6.24B
NRx Pharmaceuticals Inc (NRXPW) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
NRXPW currently screens at market cap $714.6M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the NRXPW and NTAP stock pages for the full models.
Not investment advice.